DOCSLIB.ORG

Neural Cell Markers Neural Cell Markers

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neural Cell Markers Neural Cell Markers Neural Cell Markers Neural Cell Markers Neurons and glia in neural tissue or cultures are commonly visualized and identified by immunodetection of cell-specific antigenic markers, including transcription factors, enzymes, cytoskeletal proteins, cell surface proteins, and secreted factors. The Bio-Techne brands R&D Systems and Novus Biologicals together offer an unparalleled selection of antibodies directed against these intracellular and cell surface proteins that can be used for the identification and characterization of different neural cell types. R&D Systems also offers a variety of different immunnoassays, including the gold standard Quantikine® ELISA Kits, for detecting secreted molecules. The Bio-Techne brand Tocris offers a novel and exclusive collection of tools, including bioactive small molecules, caged compounds, and fluorescent probes, for the functional identification of neural cells. Table of Contents Neuronal Markers . 1–8 General Markers. .1 Dendritic Markers. 2 Axonal Markers. 2 Presynaptic Markers. 3 Active Zone Markers. 4 Postsynaptic Markers. .4 Growth Cone Markers. .5 Cholinergic Neuron Markers. 6 Dopaminergic Neuron Markers. .6 GABAergic Neuron Markers. 7 Glutamatergic Neuron Markers. .7 Glycinergic Neuron Markers. 8 Serotonergic Neuron Markers. 8 Microglia Markers. 9–12 Steady-State Microglia Markers. .9 M1 Microglia Markers. .10–11 M2 Microglia Markers. 12 Astrocyte Markers. 13 General Markers. 13 Oligodendrocyte Markers. 14–15 Oligodendrocyte Precursor Cell Markers. .14 Immature Oligodendrocyte Markers . 14 Mature, Non-Myelinating Oligodendrocyte Markers. 15 Mature, Myelinating Oligodendrocyte Markers. 15 Additional Tools for Visualizing and Identifying Neural Cells. 16 Conjugated Primary Antibodies. 16 R&D Systems® VisUCyte™ HRP Polymer. 16 R&D Systems® Multiplex Assays . .16 Tocris® Products to Investigate Neural Function. 17 Small Molecules. 17 Caged Compounds. 17 Photoswitchable Ligands. .17 Fluorescent Probes. 17 Neuronal Markers General Markers Select R&D Systems® and Novus Biologicals® Antibodies Marker Catalog # Species Clonality Applications ◆ Calbindin D AF3320 H Poly WB, IHC ◆ Calbindin D-28K NBP2-50048 H M R + Mono WB, ICC ◆ Doublecortin NBP1-92684 H M R + Mono WB, ICC ◆ Enolase 2/Neuron- MAB5169 H Mono ICC, IHC, IP ◆ Specific Enolase AF5169 H M Poly WB, IHC, SW ◆ NBP1-92711 H M R + Mono WB, ICC MAP2 Nuclear ◆ MAB8304 H Mono ICC, IHC NeuroD1 RBFOX3/NeuN ◆ NeuroD1 AF2746 H M Poly WB, ICC Cytoplasmic ◆ NB300-135 H M R + Poly WB, ICC, IHC, ELISA Calbindin D NF-M NF-H Doublecortin PSD-93 ◆ AF3108 H Poly WB, IHC Enolase 2/Neuron- PSD-95 Specific Enolase ◆ NB300-131 H M R + Poly WB, ICC, IHC Tau NF-L MAP2 b-III Tubulin ◆ MAB2216 H Mono WB, IHC NF-H UCH-L1/PGP9.5 NF-L ◆ NB300-133 H M R + Poly WB, ICC, IHC NF-M ◆ AF3029 H Poly WB, IHC ◆ PSD-93 NB300-546 H M R Poly WB, ICC, IHC ◆ PSD-95 NB300-556 H M R + Mono WB, ICC, IHC, B/N, ChIP, FC, IP ◆ RBFOX3/NeuN NBP1-77686 H M R + Poly WB, ICC, IHC ◆ MAB3494 Ms Mono WB, IHC Tau ◆ AF3494 Ms Poly WB, IHC ◆ β-III Tubulin NB100-1612 H M R Poly WB, ICC, IHC ◆ β-III Tubulin (Clone TuJ-1), Neuron-Specific MAB1195 All Species Mono WB, ICC, SW ◆ UCH-L1/PGP9.5 MAB6007 H Mono WB, IHC, IP, SW NeuN in Mouse Brain. NeuN, also called RBFOX3, was Enolase 2 in Human Brain. Enolase 2, also called Neuron- NF-H in Human Brain. Neurofilament (NF)-H was detected in detected in immersion-fixed paraffin-embedded sections of Specific Enolase, was detected in immersion-fixed paraffin- immersion-fixed paraffin-embedded sections of human brain mouse brain using a Rabbit Anti-Human/Mouse/Rat embedded sections of human brain using a Human/Mouse using a Goat Anti-Human NF-H Antigen Affinity-Purified RBFOX3/NeuN Antigen Affinity-Purified Polyclonal Antibody Enolase 2/Neuron-Specific Enolase Antigen Affinity-Purified Polyclonal Antibody (Catalog # AF3108). The tissue was (Novus Biologicals, Catalog # NBP1-77686). The cerebellar Polyclonal Antibody (Catalog # AF5169). Prior to incubation stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit tissue was stained using HRP and DAB (brown), and with the primary antibody, the tissue was subjected to heat- (Catalog # CTS008; brown) and counterstained with counterstained with hematoxylin (blue). induced epitope retrieval using Antigen Retrieval Reagent- hematoxylin (blue). All cited reagents are from R&D Systems Basic (Catalog # CTS013). The tissue was stained using the Anti-Sheep HRP-DAB Cell & Tissue Staining Kit (Catalog # CTS019; brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm. All cited reagents are from R&D Systems. Species Key: H Human M Mouse R Rat Ms Multispecies + Additional Species Available Applications Key: B/N Blocking/Neutralization ChIP Chromatin Immunoprecipitation CyTOF CyTOF-Ready DB Dot Blot ELISA (ELISA Capture and/or Detection) EM Electron Microscopy FA Functional Assay FC Flow Cytometry GS Gel Shift ICC Immunocytochemistry IHC Immunohistochemistry IP Immunoprecipitation IV In Vitro PEP-ELISA Peptide-ELISA RI Radioimmunoassay SW Simple Western™ WB Western blot ◆ Indicates an R&D Systems® antibody ◆ Indicates a Novus Biologicals® antibody Learn more | rndsystems.com/neuralmarkers 1 Dendritic Markers Select R&D Systems® and Novus Biologicals® Antibodies Marker Catalog # Species Clonality Applications ◆ ARC/ARG3.1 NBP1-56929 H Poly WB, IHC ◆ NB100-1951 H M R + Mono WB, ICC, IHC, IP Drebrin 1 ◆ AF7739 H Poly WB, ICC, SW ◆ NBP1-92711 H M R + Mono WB, ICC MAP2 ◆ MAB8304 H Mono ICC, IHC Cytoplasmic ◆ SAP102 NBP1-87691 H M R Poly WB, IHC ARC/ARG3.1 MAP2 Drebrin 1 SAP102 Axonal Markers Select R&D Systems® and Novus Biologicals® Antibodies Marker Catalog # Species Clonality Applications ◆ Kinesin 5A NBP1-76816 H M R Poly WB, ICC, IHC, ELISA ◆ Kinesin 5B NBP2-58451 H M R Poly ICC, IHC ◆ NB100-2682 H M Mono WB, ICC, IHC, CyTOF, ELISA, FC, IP L1CAM ◆ AF277 H Poly WB, IHC ◆ NB300-135 H M R + Poly WB, ICC, IHC, ELISA Cytoplasmic NF-H Kinesin 5A NF-L ◆ AF3108 H Poly WB, IHC Kinesin 5B Peripherin ◆ NB300-131 H M R + Poly WB, ICC, IHC L1CAM Tau NF-L NF-H b-III Tubulin ◆ MAB2216 H Mono WB, IHC Cell Surface ◆ Peripherin NB300-137 H M R + Poly WB, ICC, IHC, ELISA L1CAM ◆ MAB3494 Ms Mono WB, IHC Tau ◆ AF3494 Ms Poly WB, IHC ◆ b-III Tubulin NB100-1612 H M R Poly WB, ICC, IHC ◆ b-III Tubulin (Clone TuJ-1), Neuron-Specific MAB1195 All Species Mono WB, ICC, SW MAP2 in Human Embryonic Stem Cells. Microtubule- bIII Tubulin in Neonatal Mouse Neurons. bIII Tubulin was bIII Tubulin in Differentiated Human Neural Progenitor Associated Protein 2 (MAP2) was detected in immersion- detected in fixed dissociated cell cultures of neonatal Cells. bIII Tubulin was detected in immersion-fixed fixed human embryonic stem cells/neurospheres using a mouse brain using a Chicken Anti-Human/Mouse/Rat bIII differentiated human neural progenitor cells using a Mouse Mouse Anti-Human MAP2 Monoclonal Antibody (Catalog # Tubulin Antigen Affinity-Purified Polyclonal Antibody (Novus Anti-Neuron-Specific bIII Tubulin (Clone TuJ-1) Monoclonal MAB8304). The cells were stained using the NorthernLights™ Biologicals, Catalog # NB100-1612; green). The cells were Antibody (R&D Systems, Catalog # MAB1195). The cells 557-Conjugated Donkey Anti-Mouse IgG Secondary also stained for GFAP (red) and counterstained with DAPI were stained (green) and counterstained (red). Antibody (Catalog # NL007; red) and counterstained with (blue). DAPI (blue). All cited reagents are from R&D Systems. 2 Learn more | novusbio.com/neuroscience Presynaptic Markers Select R&D Systems® and Novus Biologicals® Antibodies Marker Catalog # Species Clonality Applications Postsynatic Neuron ◆ GAP-43 NB300-143 H M R + Poly WB, ICC, IHC ◆ Neurexin 3/NRXN3 AF5269 H M Poly WB, IHC ◆ SNAP23 AF6306 H Poly WB, ICC Presynatic ◆ SNAP25 AF5946 H M R Poly WB, ICC Neuron ◆ SV2A NBP1-82964 H M R Poly WB, ICC, IHC, IP *Cytoplasmic (plasma membrane) ◆ Synapsin I NB300-104 H M R + Poly WB, ICC, IHC, IP GAP-43 SNAP25 ◆ Synapsin II NBP2-58134 H M R Poly ICC SNAP23 Syntaxin 1A ◆ Synaptogyrin 1 NBP1-77371 H M R Poly WB, ICC, IHC, ELISA *Cytoplasmic (synaptic membrane) SV2A Synaptotagmin-1 ◆ NBP2-25170 H M R + Poly WB, ICC, IHC Synapsin I Synaptotagmin-4 Synaptophysin ◆ MAB5555 H Mono ICC, IHC Synapsin II VAMP-1 Synaptogyrin 1 VAMP-2 ◆ NBP1-91499 M + Poly WB, ICC Synaptophysin Synaptotagmin-1 ◆ MAB43641 R Mono WB, IHC, IP Cell Surface ◆ Synaptotagmin-4 NBP2-13408 H Poly WB, ICC, IHC Neurexin 3/NRXN3 VIAAT/SLC32A1/VGAT VGLUT1/SLC17A7 ◆ MAB7237 H Mono WB, IHC Syntaxin 1A *Cytoplasmic marker is found associated with the ◆ AF7237 H M R Poly WB, ICC membrane of the listed cell structure. ◆ VAMP-1 AF4828 H M Poly WB, IHC ◆ VAMP-2 MAB5136 H M Mono WB, IHC ◆ NBP2-46627 H M R Mono WB, IHC VGLUT1/SLC17A7 ◆ MAB9054 H Mono IHC ◆ NBP2-20857 H M R Poly ICC, IHC VIAAT/SLC32A1/VGAT ◆ MAB6847 H Mono ICC Synapsin I in Rat Caudate Neurons. Synapsin I was Synaptotagmin-1 in Rat Spinal Cord. Synaptotagmin-1 was VAMP-1 in Mouse Spinal Cord. Vesicle-Associated detected in fixed rat caudate neurons using a Rabbit Anti- detected in perfusion-fixed frozen sections of rat spinal cord Membrane Protein 1 (VAMP-1), also called Synaptobrevin-1, Human/Mouse/Rat Synapsin I Polyclonal Antibody (Novus using a Mouse Anti-Rat Synaptotagmin-1 Monoclonal was detected in perfusion-fixed frozen sections of mouse Biologicals, Catalog # NB300-104). The cells were stained Antibody (R&D Systems, Catalog # MAB43641). The tissue spinal cord using a Goat Anti-Human/Mouse VAMP-1 (green) and then counterstained for MAP proteins (red). was stained (red) and counterstained (green). Antigen Affinity-Purified Polyclonal Antibody (Catalog # AF4828). The tissue was stained with the NorthernLights™ 557-Conjugated Donkey Anti-Goat IgG Secondary Antibody (Catalog # NL001; red) and counterstained (green).
Load more

Recommended publications
  • CCR7 Antibody (Y59) NB110-55680
    Product Datasheet CCR7 Antibody (Y59) NB110-55680 Unit Size: 0.1 ml Store at -20C. Avoid freeze-thaw cycles. Publications: 9 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NB110-55680 Updated 5/28/2019 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NB110-55680 Page 1 of 6 v.20.1 Updated 5/28/2019 NB110-55680 CCR7 Antibody (Y59) Product Information Unit Size 0.1 ml Concentration This product is unpurified. The exact concentration of antibody is not quantifiable. Storage Store at -20C. Avoid freeze-thaw cycles. Clonality Monoclonal Clone Y59 Preservative 0.01% Sodium Azide Isotype IgG Purity Tissue culture supernatant Buffer 49% PBS, 0.05% BSA and 50% Glycerol Target Molecular Weight 45 kDa Product Description Host Rabbit Gene ID 1236 Gene Symbol CCR7 Species Human, Mouse, Rat, Monkey Reactivity Notes May cross reacts with Rhesus monkey. Specificity/Sensitivity The antibody does not cross-react with other G-protein coupled receptor 1 family members. Immunogen A synthetic peptide corresponding to residues in N-terminal extracellular domain of human CKR7 was used as immunogen. Notes Produced using Abcam's RabMab® technology. RabMab® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487. Product Application Details Applications Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry- Paraffin, Immunoprecipitation, Flow Cytometry (Negative) Recommended Dilutions Western Blot 1:1000-10000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:250, Immunoprecipitation 1:10, Immunohistochemistry-Paraffin 1:250, Immunohistochemistry-Frozen 1:250, Flow Cytometry (Negative) Application Notes This product is useful for: Western Blot, Immunohistochemistry-Paraffin, Immunocytochemistry, Immunoprecipitation.
    [Show full text]
  • Eradication of ENO1-Deleted Glioblastoma Through Collateral Lethality
    bioRxiv preprint doi: https://doi.org/10.1101/331538; this version posted May 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Eradication of ENO1-deleted Glioblastoma through Collateral Lethality Yu-Hsi Lin1, Nikunj Satani1,2, Naima Hammoudi1, Jeffrey J. Ackroyd1, Sunada Khadka1, Victoria C. Yan1, Dimitra K. Georgiou1, Yuting Sun3, Rafal Zielinski4, Theresa Tran1, Susana Castro Pando1, Xiaobo Wang1, David Maxwell5, Zhenghong Peng6, Federica Pisaneschi1, Pijus Mandal7, Paul G. Leonard8, Quanyu Xu,9 Qi Wu9, Yongying Jiang9, Barbara Czako10, Zhijun Kang10, John M. Asara11, Waldemar Priebe4, William Bornmann12, Joseph R. Marszalek3, Ronald A. DePinho13 and Florian L. Muller#1 1) Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 2) Institute of Stroke and Cerebrovascular Disease, The University of Texas Health Science Center at Houston, TX 77030 3) Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 4) Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 5) Institutional Analytics & Informatics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 6) Cardtronics, Inc., Houston, TX 77042 7) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 bioRxiv preprint doi: https://doi.org/10.1101/331538; this version posted May 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Memoranaurns by the Participants in Signes Par Les Partici- I the Meeting
    Memoranda are state- Les Memorandums ments concerning the exposent les conclu- /e , conclusions or recom- sions et recomman- M e mmooranrantedaa mendations of certain dations de certaines / a t w / /WHO scientific meet- /reunions scientifiques ings; they are signed de /'OMS; ils sont Memoranaurns by the participants in signes par les partici- I the meeting. pants a ces reunions. Bulletin ofthe World Health Organization, 62 (2): 217-227 (1984) © World Health Organization 1984 Immunodiagnosis simplified: Memorandum from a WHO Meeting* Technologies suitable for the development ofsimplified immunodiagnostic tests were reviewed by a Working Group of the WHO Advisory Committee on Medical Research in Geneva in June 1983. They included agglutination tests and use ofartificialparticles coated with immunoglobulins, direct visual detection of antigen-antibody reactions, enzyme- immunoassays, and immunofluorescence and fluoroimmunoassays. The use of mono- clonal antibodies,in immunodiagnosis and of DNA /RNA probes to identify viruses was also discussed in detail. The needfor applicability of these tests at three levels, i.e., field conditions (or primary health care level), local laboratories, and central laboratories, was discussed and their use at thefield level was emphasized. Classical serological techniques have been used for All these tests can be carried out in laboratories that a long time for diagnostic purposes, e.g., for con- are equipped with basic instruments as well as special- firmation of clinical diagnoses, epidemiological ized apparatus (e.g., gamma counters for RIA, ultra- studies, testing of blood donors, etc. Some of these violet microscopes for IMF, etc.), which are usually techniques have been standardized to a high degree of available only in the larger, central laboratories.
    [Show full text]
  • Cytokine Immunocytochemistry Fax (65) 860-1590 Fax (49) 40 531 58 92 Fax (81) 3 541-381-55 E-Mail: [email protected]
    PharMingen International United States Canada PharMingen Europe Japan PharMingen Canada Tel 619-812-8800 Asia Pacific Becton Dickinson GmbH Nippon Becton Dickinson Toll-Free 1-888-259-0187 Orders 1-800-848-6227 BD Singapore HQ PharMingen Europe Company Ltd. Tel 905-542-8028 Tech Service 1-800-825-5832 Tel (65) 860-1478 Tel (49) 40 532 84 48 0 Tel (81) 3 541-382-51 Fax 905-542-9391 Fax 619-812-8888 Cytokine Immunocytochemistry Fax (65) 860-1590 Fax (49) 40 531 58 92 Fax (81) 3 541-381-55 e-mail: [email protected] http://www.pharmingen.com Africa Germany Latin/South America Spain Becton Dickinson Worldwide Inc. Becton Dickinson GmbH BDIS (USA) Becton Dickinson S.A. Reagents and Techniques Tel (254) 2 449 608 HQ PharMingen Europe Tel (408) 954-2157 Tel (34) 91 848 8100 Fax (254) 2 449 619 Tel (49) 40 532 84 48 0 Fax (408) 526-1804 Fax (34) 91 848 8105 Fax (49) 40 531 58 92 Orders for Microscopic Analysis of Cytokine-Producing Cells Australia Malaysia Tel (34) 91 848 8182 Becton Dickinson Pty Ltd Greece Becton Dickinson Sdn Bhd Fax (34) 91 848 8104 Tel (612) 9978-6800 Becton Dickinson Hellas S.A. Tel (03) 7571323 Fax (612) 9978-6850 Tel (30) 1 9407741 Fax (03) 7571153 Sweden Fax (30) 1 9407740 Becton Dickinson AB Austria Mexico Tel (46) 8 775 51 00 Becton Dickinson GmbH Hong Kong Becton Dickinson de Mexico Fax (46) 8 645 08 08 HQ PharMingen Europe Becton Dickinson Asia Ltd Tel (52-5) 237-12-98 Tel (49) 40 532 84 48 0 Tel (852) 2572-8668 Fax (52-5) 237-12-93 Switzerland Fax (49) 40 531 58 92 Fax (852) 2520-1837 Becton Dickinson GmbH Middle East HQ PharMingen Europe Belgium Hungary Becton Dickinson Tel (41) 06 1-385 4422 Becton Dickinson Benelux N.V.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Apoptotic Genes As Potential Markers of Metastatic Phenotype in Human Osteosarcoma Cell Lines
    17-31 10/12/07 14:53 Page 17 INTERNATIONAL JOURNAL OF ONCOLOGY 32: 17-31, 2008 17 Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines CINZIA ZUCCHINI1, ANNA ROCCHI2, MARIA CRISTINA MANARA2, PAOLA DE SANCTIS1, CRISTINA CAPANNI3, MICHELE BIANCHINI1, PAOLO CARINCI1, KATIA SCOTLANDI2 and LUISA VALVASSORI1 1Dipartimento di Istologia, Embriologia e Biologia Applicata, Università di Bologna, Via Belmeloro 8, 40126 Bologna; 2Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; 3IGM-CNR, Unit of Bologna, c/o Istituti Ortopedici Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy Received May 29, 2007; Accepted July 19, 2007 Abstract. Metastasis is the most frequent cause of death among malignant primitive bone tumor, usually developing in children patients with osteosarcoma. We have previously demonstrated and adolescents, with a high tendency to metastasize (2). in independent experiments that the forced expression of Metastases in osteosarcoma patients spread through peripheral L/B/K ALP and CD99 in U-2 OS osteosarcoma cell lines blood very early and colonize primarily the lung, and later markedly reduces the metastatic ability of these cancer cells. other skeleton districts (3). Since disseminated hidden micro- This behavior makes these cell lines a useful model to assess metastases are present in 80-90% of OS patients at the time the intersection of multiple and independent gene expression of diagnosis, the identification of markers of invasiveness signatures concerning the biological problem of dissemination. and metastasis forms a target of paramount importance in With the aim to characterize a common transcriptional profile planning the treatment of osteosarcoma lesions and enhancing reflecting the essential features of metastatic behavior, we the prognosis.
    [Show full text]
  • Rabbit Mab A
    Revision 1 C 0 2 - t Enolase-2 (D20H2) Rabbit mAb a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 1 7 Web: [email protected] 1 www.cellsignal.com 8 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source/Isotype: UniProt ID: Entrez-Gene Id: WB, IP H M R Mk Endogenous 47 Rabbit IgG P09104 2026 Product Usage Information Application Dilution Western Blotting 1:1000 Immunoprecipitation 1:50 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity Enolase-2 (D20H2) Rabbit mAb recognizes endogenous levels of total enolase-2 protein. May cross-react with exogenous levels of enolase-1. Species Reactivity: Human, Mouse, Rat, Monkey Source / Purification Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human enolase-2 protein. Background Enolase is a glycolytic enzyme that is involved in the conversion of 2-phosphoglycerate to phosphoenolpyruvate (1). Mammalian enolase has three subunits: α, β, and γ, that can form homo and heterodimers. Homodimers of γ enolase are neuronal-specific (2). Research studies have shown elevated levels of neuro-specific enolase-2 in neuroblastoma (2) and small-cell lung cancer (3,4). 1. Van Obberghen, E. et al. (1988) J Neurosci Res 19, 450-6. 2.
    [Show full text]
  • The Splicing Regulator Rbfox1 (A2BP1) Controls Neuronal Excitation in the Mammalian Brain
    LETTERS The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain Lauren T Gehman1, Peter Stoilov2, Jamie Maguire3, Andrey Damianov4, Chia-Ho Lin4, Lily Shiue5, Manuel Ares Jr5, Istvan Mody6,7 & Douglas L Black1,4,8 The Rbfox family of RNA binding proteins regulates alternative The three mouse Rbfox paralogues show a high degree of sequence splicing of many important neuronal transcripts, but its role in conservation, especially within the RNA binding domain, which is neuronal physiology is not clear1. We show here that central identical in Rbfox1 and Rbfox2 and is only slightly altered in Rbfox3 nervous system–specific deletion of the gene encoding Rbfox1 (94% amino acid identity). Rbfox1 is specifically expressed in neurons, results in heightened susceptibility to spontaneous and kainic heart and muscle6,18, whereas Rbfox2 is expressed in these tissues acid–induced seizures. Electrophysiological recording revealed and in other cell types, including the embryo, hematopoetic cells and a corresponding increase in neuronal excitability in the dentate embryonic stem cells6,19,20. Expression of Rbfox3 is limited to neu- gyrus of the knockout mice. Whole-transcriptome analyses rons21,22. In the mature brain, most neurons express all three Rbfox identified multiple splicing changes in the Rbfox1−/− brain with paralogs, but certain neuronal subtypes and sporadic individual cells few changes in overall transcript abundance. These splicing can be seen that express only one or two of the proteins23 (Fig. 1a). changes alter proteins that mediate synaptic transmission and All three proteins have similar N- and C-terminal domains that are membrane excitation. Thus, Rbfox1 directs a genetic program diversified by alternative promoter use and alternative splicing to required in the prevention of neuronal hyperexcitation and produce a cohort of related protein isoforms with variable localization seizures.
    [Show full text]
  • AG 39: Immunofluorescence Assays (PDF)
    ibidi Application Guide Immunofluorescence Assays The Principle of Immunofluorescence Immunofluorescence Applied: Assays . 2 Experimental Examples . 13 Rat Hippocampal Neuron and Astrocyte Staining 14 Immunofluorescence Staining: Visualization of Endothelial Cell Junctions . 13 A Typical Workflow . 3 Immunostaining of Rat Dorsal Root Ganglionic Experiment Planning and Sample Preparation . 4 Cells and Schwann Cells . 13 Sample Fixation . 4 Adherens Junctions and Actin Cytoskeleton of Cell Permeabilization . 5 HUVECs Under Flow . 14 Blocking . 5 Mitochondria Staining of MDCK cells . 14 Primary Antibody Incubation . 5 Focal Adhesions of Differentiated Mouse Fibroblasts on an Elastic Surface . 15 Secondary Antibody Incubation . 6 Counterstain and Mounting . 7 Microscopy . 7 Troubleshooting . 8 Selected Publications Immunofluorescence C. Xu, et al. NPTX2 promotes colorectal cancer growth and liver With the ibidi Chambers . 9 metastasis by the activation of the canonical Wnt/beta-catenin pathway via FZD6. Cell Death & Disease, 2019, 10.1038/s41419- Comparison of Immunocytochemistry Protocols . 10 019-1467-7 Chambered Coverslips . 11 read abstract Kobayashi, T., et al. Principles of early human development and Channel Slides . 11 germ cell program from conserved model systems. Nature, Chamber Slides . 12 2017, 10.1038/nature22812 read abstract H. Tada et al. Porphyromonas gingivalis Gingipain-Dependently Enhances IL-33 Production in Human Gingival Epithelial Cells. PloS one, 2016, 10.1371/journal.pone.0152794 read abstract N. J. Foy, M. Akhrymuk, A. V. Shustov, E. I. Frolova and I. Frolov. Hypervariable Domain of Nonstructural Protein nsP3 of Venezuelan Equine Encephalitis Virus Determines Cell-Specific Mode of Virus Replication. Journal of Virology, 2013, 10.1128/ jvi.00720-13 read abstract .com The Principle of Immunofluorescence Assays Immunofluorescence (IF) is a powerful approach for getting insight into cellular structures and processes using microscopy .
    [Show full text]
  • Neuron Specific Enolase (NSE) ELISA Kit
    Package Insert Neuron Specific Enolase (NSE) ELISA Kit Catalog Number: NSE31-K01 (1 x 96 wells) For Research Use Only. Not for use in diagnostic procedures. v. 1.0 Eagle Biosciences, Inc. 20A Northwest Blvd., Suite 112, Nashua, NH 03063 Phone: 617-419-2019 Fax: 617-419-1110 www.EagleBio.com INTENDED USE The Eagle Biosciences Human Neuron Specific Enolase (NSE) ELISA Assay Kit (enzyme-linked immunoassay kit) is intended for the quantitative determination of human neuron specific enolase (NSE) levels in serum. The Eagle Biosciences Human Neuron Specific (NSE) ELISA Assay Kit is for research use only and not to be used in diagnostic procedures. INTRODUCTION The glycolytic enzyme enolase (2-phospho-D-glycerate hydrolyase) exists as several dimeric isoenzymes (αα, αβ, ββ and γγ) composed of three distinct subunits: α, β, and γ. Three isoenzymes are found in human brain: αα, αβ, and γγ. The heterologous αγ-isoenzyme and the homologous γγ -enolase isoenzymes are known as neuron-specific enolase (NSE) as these isoenzymes initially were detected in neurons and neuroendocrine cells. By using monoclonal antibodies specific to the γ-subunit of the enzyme allow the test to detect both the αγ and the γγ forms. The NSE levels are quite low in normal healthy people and in people with benign disease. Lung cancer is one of the most common cancer forms with incidences about 50-100 per 100,000 population. Approximately 20% of the lung cancer is small cell lung cancer. NSE has been shown to be a valuable tumor marker of neuroendocrine origin, particularly in small cell lung cancer and in neuroblastoma.
    [Show full text]
  • In-Depth Proteomic Analysis of Tissue Interstitial Fluid for Hepatocellular Carcinoma Serum Biomarker Discovery
    FULL PAPER British Journal of Cancer (2017) 117, 1676–1684 | doi: 10.1038/bjc.2017.344 Keywords: biomarker; tissue interstitial fluid; hepatocellular carcinoma; proteomics; prognosis In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery Jian Zhang1, Ning Hao1, Wei Liu2, Min Lu3, Longqin Sun1, Ning Chen1, Miantao Wu4, Xiaohang Zhao5, Baocai Xing2,7, Wei Sun*,1,7 and Fuchu He*,1,6,7 1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences Beijing, Beijing Institute of Radiation Medicine, Beijing 102206, China; 2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery I, Peking University Cancer Hospital and Institute, Beijing 100036, China; 3Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; 4State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; 5State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China and 6Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China Background: Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. New serum biomarkers for HCC screening are needed, especially for alpha-fetoprotein (AFP) negative patients. As a proximal fluid between body fluids and intracellular fluid, tissue interstitial fluid (TIF) is a suitable source for serum biomarker discovery. Methods: Sixteen paired TIF samples from HCC tumour and adjacent non-tumour tissues were analysed by isobaric tags for relative and absolute quantitation (iTRAQ) method.
    [Show full text]
  • 116588NCJRS.Pdf
    If you have issues viewing or accessing this file contact us at NCJRS.gov. " "'- u.s. Department of Justice Federal Bureau of Investigation PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON FORENSIC IMMUNOLOGY FBI ACADEMY QUANTICO, VIRGINIA JUNE 23-26, 1986 Proceedings of the International Symposium on Forensic Immunology co 00 L() \0 u, r-l O§ r-l Ql C. If) 05~ Ql 0- 0 ~ o~ Ql E C/) Ql >. c:0 If) C/) ~ * ....,a: () a: z Ql '*02 Ql iii :5 ...... ....,::> a Ql {ij "...:0- Ql c: !!lc: °E ::>;: B 00 {ij c: 0 ~I::> z~ "e CD ~~ :5 .... ~o- S 1::C: Lt .~ Host Laboratory Division Federal Bureau of Investigation June 23-26, 1986 Forensic Science Research and Training Center FBI Academy Quantico, Virginia NOTICE This publication was prepared by the U. S. Government. Neither the U. S. Government nor the U. S. Department of Justice nor any of their employees makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness or usefulness of any information, apparatus, product or process disclosed, or represents that in use would not infringe privately owned rights. Reference herein to any specific commercial product, process or service by trade name, mark, manufacturer or otherwise does not necessarily constitute or imply its endorsement, recommendation or favoring by the U. S. Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the U. S. Government or any agency thereof. Published by: The Laboratory Division Roger T. Castonguay Assistant Director in Charge Federal Bureau of Investigation U.
    [Show full text]